MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    RAB12 variants and their role in dystonia

    K. Lohmann, E. Hebert, F. Borngräber, A. Schmidt, A. Rakovic, A. Weissbach, J. Hampf, E.-J. Vollstedt, S. Schaake, H. Manzoor, H.-C. Jabusch, M. Kasten, V. Kostic, T. Gasser, K. Zeuner, P. Bauer, E. Altenmüller, C. Klein (Luebeck, Germany)

    Objective: To evaluate the role of mutations in RAB12 in different forms of dystonia. Background: By next generation sequencing, we recently identified an extremely rare…
  • 2017 International Congress

    EMG-US guided incobotulinum toxinA treatment of a cohort of musicians affected by upper limb focal dystonia

    A. Castagna, M. Ramella, G. Giacobbi, P. Cecconi, R. Converti (Milano, Italy)

    Objective: To demonstrate the efficacy and safety of incobotulinumtoxinA  and the importance of simultaneous US and EMG guide in targeting single finger muscles in musician’s…
  • 2017 International Congress

    Head turning onset and velocity in response to a peripheral visual stimulus in cervical dystonia patients, their unaffected relatives with and without abnormal temporal discrimination and healthy controls.

    I. Beiser, B. Quinlivan, E. McGovern, L. Williams, S. Narasimham, O. Killian, R. Beck, S. O'Riordan, J. Butler, R. Reilly, M. Hutchinson (Dublin 4, Ireland)

    Objective: We postulate that cephalomotor responses (onset of head turning and speed of head turning) to the appearance of a novel peripheral visual stimulus will…
  • 2017 International Congress

    Brain volume changes in relation to intracortical inhibition and clinical benefit of pallidal stimulation in dystonia: a combined VBM and TMS study.

    R. Jech, A. Fečíková, V. Čejka, V. Čapek, D. Šťastná, F. Růžička, D. Urgošík, E. Růžička (Prague, Czech Republic)

    Objective: To explore the relationship between brain morphology, clinical effects of bilateral pallidal stimulation (GPi DBS) and intracortical inhibition of the motor cortex in patients…
  • 2017 International Congress

    Disrupted superior collicular activity may reveal cervical dystonia disease pathomechanisms

    E. Mc Govern, O. Killian, S. Narasimham, B. Quinlivan, I. Beiser, L. Williams, R. Beck, J. Butler, S. O'Riordan, R. Reilly, M. Hutchinson (Dublin, Ireland)

    Objective: To assess by functional magnetic resonance imaging, the response of the superior colliculi to a looming stimulus in cervical dystonia patients and their unaffected…
  • 2017 International Congress

    Clinical Relevance of Treatment With OnabotulinumtoxinA in Patients With Cervical Dystonia: Results From the CD Probe Study

    K. Dashtipour, Z. Mari, J. Jankovic, C. Adler, M. Schwartz, M. Brin (Loma Linda, CA, USA)

    Objective: To explore minimal clinically important change perceived by patients as beneficial by the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) using data from the…
  • 2017 International Congress

    Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)

    S. Factor, M. Silver, J. Hanfelt, E. Sperine, L. Scorr, A. Freeman, H. Jinnah (Atlanta, GA, USA)

    Objective: To examine the safety and efficacy of AboA in OMD Background: OMD causes involuntary movements of the lower facial, masticatory, and lingual muscles.  The…
  • 2017 International Congress

    Dystonia treatment in an international cohort: a longitudinal analysis

    S. Pirio Richardson, A. Wegele, A. Deligtisch, F. Qeadan (Albuquerque, NM, USA)

    Objective: To assess the change in therapy for dystonia over time Background: Although botulinum toxin (BoNT) injections are the gold standard therapy for patients with focal…
  • 2017 International Congress

    Combined effects of rTMS and botulinum toxin therapy in benign essential blepharospasm

    A. Wagle Shukla, J. Legacy, W. Deeb, W. Hu (Gainesville, FL, USA)

    Objective: To determine whether repetitive transcranial magnetic stimulation (rTMS) of anterior cingulate cortex (ACC) when added to botulinum toxin (BoNT) therapy improves benign essential blepharospasm…
  • 2017 International Congress

    A Comparison of Temporal Discrimination Thresholds in Musicians with and without Dystonia

    O. Killian, K. Simonyan, E. McGovern, B. Quinlivan, S. Narasimham, I. Beiser, J. Butler, R. Beck, S. O'Riordan, M. Hutchinson, R. Reilly (Dublin, Ireland)

    Objective: To compare the Temporal Discrimination Thresholds (TDT) of Musician’s Dystonia (MD) patients with those of healthy control musicians. Background: The TDT is a measure…
  • « Previous Page
  • 1
  • …
  • 1311
  • 1312
  • 1313
  • 1314
  • 1315
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley